Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line
- PMID: 29272854
- PMCID: PMC5975227
- DOI: 10.1016/j.redox.2017.12.003
Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line
Abstract
Monocytes/macrophages are thought to be recruited to the renal interstitium during calcium oxalate (CaOx) kidney stone disease for crystal clearance. Mitochondria play an important role in monocyte function during the immune response. We recently determined that monocytes in patients with CaOx kidney stones have decreased mitochondrial function compared to healthy subjects. The objective of this study was to determine whether oxalate, a major constituent found in CaOx kidney stones, alters cell viability, mitochondrial function, and redox homeostasis in THP-1 cells, a human derived monocyte cell line. THP-1 cells were treated with varying concentrations of CaOx crystals (insoluble form) or sodium oxalate (NaOx; soluble form) for 24h. In addition, the effect of calcium phosphate (CaP) and cystine crystals was tested. CaOx crystals decreased cell viability and induced mitochondrial dysfunction and redox imbalance in THP-1 cells compared to control cells. However, NaOx only caused mitochondrial damage and redox imbalance in THP-1 cells. In contrast, both CaP and cystine crystals did not affect THP-1 cells. Separate experiments showed that elevated oxalate also induced mitochondrial dysfunction in primary monocytes from healthy subjects. These findings suggest that oxalate may play an important role in monocyte mitochondrial dysfunction in CaOx kidney stone disease.
Keywords: Calcium oxalate; Kidney stones; Mitochondria; MnSOD; Monocytes; Sodium oxalate.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Figures









Similar articles
-
Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages.Front Immunol. 2021 Oct 21;12:694865. doi: 10.3389/fimmu.2021.694865. eCollection 2021. Front Immunol. 2021. PMID: 34745086 Free PMC article.
-
Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages.Front Immunol. 2018 Aug 22;9:1863. doi: 10.3389/fimmu.2018.01863. eCollection 2018. Front Immunol. 2018. PMID: 30186283 Free PMC article.
-
Dietary Oxalate Loading Impacts Monocyte Metabolism and Inflammatory Signaling in Humans.Front Immunol. 2021 Feb 25;12:617508. doi: 10.3389/fimmu.2021.617508. eCollection 2021. Front Immunol. 2021. PMID: 33732242 Free PMC article.
-
Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.Front Immunol. 2021 May 24;12:673690. doi: 10.3389/fimmu.2021.673690. eCollection 2021. Front Immunol. 2021. PMID: 34108970 Free PMC article.
-
Immunotherapy for stone disease.Curr Opin Urol. 2020 Mar;30(2):183-189. doi: 10.1097/MOU.0000000000000729. Curr Opin Urol. 2020. PMID: 31913203 Review.
Cited by
-
Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages.Front Immunol. 2021 Oct 21;12:694865. doi: 10.3389/fimmu.2021.694865. eCollection 2021. Front Immunol. 2021. PMID: 34745086 Free PMC article.
-
Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence.Asian J Urol. 2023 Jul;10(3):246-257. doi: 10.1016/j.ajur.2023.01.008. Epub 2023 Apr 13. Asian J Urol. 2023. PMID: 37538166 Free PMC article. Review.
-
Hydroxycitric acid prevents hyperoxaluric-induced nephrolithiasis and oxidative stress via activation of the Nrf2/Keap1 signaling pathway.Cell Cycle. 2023 Sep;22(17):1884-1899. doi: 10.1080/15384101.2023.2247251. Epub 2023 Aug 17. Cell Cycle. 2023. PMID: 37592762 Free PMC article.
-
Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.Cell Rep. 2021 Jul 27;36(4):109420. doi: 10.1016/j.celrep.2021.109420. Cell Rep. 2021. PMID: 34320345 Free PMC article.
-
Plants Used in Mexican Traditional Medicine for the Management of Urolithiasis: A Review of Preclinical Evidence, Bioactive Compounds, and Molecular Mechanisms.Molecules. 2022 Mar 21;27(6):2008. doi: 10.3390/molecules27062008. Molecules. 2022. PMID: 35335370 Free PMC article. Review.
References
-
- Fink H.A., Wilt T.J., Eidman K.E. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann. Intern. Med. 2013;158:535–543. - PubMed
-
- Holmes R.P., Assimos D.G. The impact of dietary oxalate on kidney stone formation. Urol. Res. 2004;32:311–316. - PubMed
-
- Goodman H.O., Brommage R., Assimos D.G., Holmes R.P. Genes in idiopathic calcium oxalate stone disease. World J. Urol. 1997;15:186–194. - PubMed
-
- Khan S.R. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol. Res. 1995;23:71–79. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous